We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$216B
AUM Growth
-$14.8B
Cap. Flow
-$26.7B
Cap. Flow %
-12.35%
Top 10 Hldgs %
20.98%
Holding
10,716
New
1,138
Increased
3,488
Reduced
4,567
Closed
1,373

Sector Composition

Rank Sector Weight
1 Technology 3.05%
2 Financials 2.16%
3 Consumer Discretionary 1.64%
4 Communication Services 1.43%
5 Healthcare 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOF icon
9651
Coca-Cola Femsa
KOF
$24.1B
-6,550
Closed -$454K
KOF icon
9652
PUT
Coca-Cola Femsa
KOF
$24.1B
-10,400
Closed -$722K
KRC icon
9653
PUT
Kilroy Realty
KRC
$4.29B
-3,200
Closed -$209K
KRO icon
9654
CALL
KRONOS Worldwide
KRO
$1B
-26,600
Closed -$165K
KRO icon
9655
PUT
KRONOS Worldwide
KRO
$1B
-16,100
Closed -$100K
KW
9656
PUT
DELISTED
Kennedy-Wilson Holdings
KW
-11,700
Closed -$259K
LAB icon
9657
Standard BioTools
LAB
$263M
-48,890
Closed -$480K
LABD icon
9658
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$64.2M
-18
Closed -$1.38M
LABU icon
9659
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$670M
-150
Closed -$243K
LBTYA icon
9660
Liberty Global Class A
LBTYA
$3.66B
-10,897
Closed -$411K
LCII icon
9661
PUT
LCI Industries
LCII
$2.54B
-9,000
Closed -$491K
LCTX icon
9662
Lineage Cell Therapeutics
LCTX
$276M
-64,116
Closed -$192K
LCTX icon
9663
PUT
Lineage Cell Therapeutics
LCTX
$276M
-50,923
Closed -$123K
LEE icon
9664
Lee Enterprises
LEE
$184M
-5,142
Closed -$107K
LEG icon
9665
CALL
Leggett & Platt
LEG
$1.28B
-32,300
Closed -$1.33M
LEG icon
9666
PUT
Leggett & Platt
LEG
$1.28B
-41,500
Closed -$1.71M
LEMB icon
9667
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$728M
-46,361
Closed -$1.84M
LFCR icon
9668
CALL
Lifecore Biomedical
LFCR
$172M
-12,600
Closed -$147K
LFUS icon
9669
PUT
Littelfuse
LFUS
$10.2B
-22,800
Closed -$2.08M
LIT icon
9670
Global X Lithium & Battery Tech ETF
LIT
$1.65B
-24,800
Closed -$461K
LMBS icon
9671
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.42B
-12,648
Closed -$636K
LNTH icon
9672
Lantheus
LNTH
$6.58B
-40,737
Closed -$175K
LOB icon
9673
Live Oak Bancshares
LOB
$1.87B
-16,995
Closed -$334K
LOPE icon
9674
CALL
Grand Canyon Education
LOPE
$3.85B
-16,600
Closed -$631K
LPSN icon
9675
LivePerson
LPSN
$33.2M
-11,556
Closed -$1.31M

Similar funds

Jeff Yass's Q4 2015 Portfolio in Review

As of Q4 2015, Jeff Yass held 10,716 positions worth $216B, down 6.4% from $231B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Jeff Yass withdrew a net $26.7B in Q4 2015, closing 1,373 positions and reducing 4,567 holdings. Its most notable exit was Altera Corp, an estimated $97.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, up from 2.9% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jeff Yass opened a new position in Alphabet (Google) Class A worth $510M.

  • Jeff Yass's largest Q4 2015 buy was Alphabet (Google) Class A: 13,098,340 shares worth $510M.
  • Jeff Yass added most to Synchrony in Q4 2015, an estimated $683M increase.
  • Jeff Yass's biggest Q4 2015 reduction was DuPont de Nemours, cutting an estimated $805M.
  • Jeff Yass fully exited Altera Corp in Q4 2015, selling an estimated $97.3M.
  • Jeff Yass's ten largest holdings make up 21% of its $216B portfolio in Q4 2015.
  • Jeff Yass opened 1,138 new positions and closed 1,373 in Q4 2015.
  • Jeff Yass's portfolio value fell 6.4% quarter-over-quarter to $216B.

Based on Susquehanna International Group's 13F filing for Q4 2015, filed 16 Feb 2016.